Anti-Diabetic Drugs Market 2019 Global Analysis, Opportunities and Forecast to 2025

Anti-Diabetic Drugs Market –Market Demand, Growth, Opportunities, Analysis of Top Key Players and Forecast to 2025

Pune, India - March 22, 2019 /MarketersMedia/ —

Anti-Diabetic Drugs Market 2019

Wiseguyreports.Com adds “Anti-Diabetic Drugs Market –Market Demand, Growth, Opportunities, Analysis of Top Key Players and Forecast to 2025” To Its Research Database.

Report Details:

This report provides in depth study of “Anti-Diabetic Drugs Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Anti-Diabetic Drugs Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

The anti-diabetics market includes drugs, which are used for treatment of diabetes mellitus and are also known as oral hypoglycemic/antihyperglycemic agents. The anti-diabetics market has grown tremendously in recent years with increasing prevalence of diabetes mellitus. Thus, systemic therapies for diabetes have become the focal point of attention due to the burgeoning diabetic population size, with diabetes affecting middle age groups and children across all income groups globally. 
Some of the major drivers and opportunities for growth of this market include drug combinations of several agents such as sitagliptin and metformin and other drug combinations that are in different stages of clinical and pipeline development. Increase in the prevalence of diabetes and new product launches by major pharmaceutical companies re some of the key drivers for growth in this market. In 2015, Boehringer Ingelheim GmbH launched two new drugs (Synjardy & Glyxambi)for treatment of diabetes mellitus type II.  
Some of the key opportunities for the antidiabetics include a strong pipeline for antidiabetics and entry of new players in the market, for instance, Novo Nordisk's diabetes drug’s Tresiba, and Ryzodeg received FDA approval in September 2015. Moreover, Boehringer Ingelheim GmbH has a strong pipeline for anti-diabetic drugs, such as Linagliptin which is a dipeptidyl peptidase (DPP) 4 inhibitor) for patients suffering from diabetes mellitus type II and high cardiovascular risk. 

The global Anti-Diabetic Drugs market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. 
This report focuses on Anti-Diabetic Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Anti-Diabetic Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan. 
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered: 
Astra Zeneca 
Boehringer Ingelheim 
Eli Lilly 
Johnson & Johnson 
Merck 
Novartis 
Novo Nordisk 
Sanofi 
Teva Pharmaceutical Industries

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/3825670-global-anti-diabetic-drugs-market-research-report-2019

Segment by Type 
Biguanides 
Sulfonylureas 
Meglitinides 
Thiazolidinediones 
Dipeptidyl Peptidase IV Inhibitors 
α-Glucosidase Inhibitors

Segment by Application 
Type I Diabetes 
Type II Diabetes 
Others

Segment by Regions
North America 
China 
India 
Japan 
Europe 

Key Stakeholders 
Anti-Diabetic Drugs Manufacturers 
Anti-Diabetic Drugs Distributors/Traders/Wholesalers 
Anti-Diabetic Drugs Subcomponent Manufacturers 
Industry Association 
Downstream Vendors

If you have any special requirements, please let us know and we will offer you the report as you want.

Complete Report Details@  https://www.wiseguyreports.com/reports/3825670-global-anti-diabetic-drugs-market-research-report-2019

Major Key Points in Table of Content:

1 Anti-Diabetic Drugs Market Overview 
1.1 Product Overview and Scope of Anti-Diabetic Drugs 
1.2 Anti-Diabetic Drugs Segment by Type 
1.2.1 Global Anti-Diabetic Drugs Production Growth Rate Comparison by Type (2014-2025) 
1.2.2 Biguanides 
1.2.3 Sulfonylureas 
1.2.4 Meglitinides 
1.2.5 Thiazolidinediones 
1.2.6 Dipeptidyl Peptidase IV Inhibitors 
1.2.7 α-Glucosidase Inhibitors 
1.3 Anti-Diabetic Drugs Segment by Application 
1.3.1 Anti-Diabetic Drugs Consumption Comparison by Application (2014-2025) 
1.3.2 Type I Diabetes 
1.3.3 Type II Diabetes 
1.3.4 Others 
1.4 Global Anti-Diabetic Drugs Market by Region 
1.4.1 Global Anti-Diabetic Drugs Market Size Region 
1.4.2 North America Status and Prospect (2014-2025) 
1.4.3 Europe Status and Prospect (2014-2025) 
1.4.4 China Status and Prospect (2014-2025) 
1.4.5 Japan Status and Prospect (2014-2025) 
1.5 Global Anti-Diabetic Drugs Market Size 
1.5.1 Global Anti-Diabetic Drugs Revenue (2014-2025) 
1.5.2 Global Anti-Diabetic Drugs Production (2014-2025)

….

7 Company Profiles and Key Figures in Anti-Diabetic Drugs Business 
7.1 Astra Zeneca 
7.1.1 Astra Zeneca Anti-Diabetic Drugs Production Sites and Area Served 
7.1.2 Anti-Diabetic Drugs Product Introduction, Application and Specification 
7.1.3 Astra Zeneca Anti-Diabetic Drugs Production, Revenue, Price and Gross Margin (2014-2019) 
7.1.4 Main Business and Markets Served 
7.2 Boehringer Ingelheim 
7.2.1 Boehringer Ingelheim Anti-Diabetic Drugs Production Sites and Area Served 
7.2.2 Anti-Diabetic Drugs Product Introduction, Application and Specification 
7.2.3 Boehringer Ingelheim Anti-Diabetic Drugs Production, Revenue, Price and Gross Margin (2014-2019) 
7.2.4 Main Business and Markets Served 
7.3 Eli Lilly 
7.3.1 Eli Lilly Anti-Diabetic Drugs Production Sites and Area Served 
7.3.2 Anti-Diabetic Drugs Product Introduction, Application and Specification 
7.3.3 Eli Lilly Anti-Diabetic Drugs Production, Revenue, Price and Gross Margin (2014-2019) 
7.3.4 Main Business and Markets Served 
7.4 Johnson & Johnson 
7.4.1 Johnson & Johnson Anti-Diabetic Drugs Production Sites and Area Served 
7.4.2 Anti-Diabetic Drugs Product Introduction, Application and Specification 
7.4.3 Johnson & Johnson Anti-Diabetic Drugs Production, Revenue, Price and Gross Margin (2014-2019) 
7.4.4 Main Business and Markets Served 
7.5 Merck 
7.5.1 Merck Anti-Diabetic Drugs Production Sites and Area Served 
7.5.2 Anti-Diabetic Drugs Product Introduction, Application and Specification 
7.5.3 Merck Anti-Diabetic Drugs Production, Revenue, Price and Gross Margin (2014-2019) 
7.5.4 Main Business and Markets Served 
7.6 Novartis 
7.6.1 Novartis Anti-Diabetic Drugs Production Sites and Area Served 
7.6.2 Anti-Diabetic Drugs Product Introduction, Application and Specification 
7.6.3 Novartis Anti-Diabetic Drugs Production, Revenue, Price and Gross Margin (2014-2019) 
7.6.4 Main Business and Markets Served 
7.7 Novo Nordisk 
7.7.1 Novo Nordisk Anti-Diabetic Drugs Production Sites and Area Served 
7.7.2 Anti-Diabetic Drugs Product Introduction, Application and Specification 
7.7.3 Novo Nordisk Anti-Diabetic Drugs Production, Revenue, Price and Gross Margin (2014-2019) 
7.7.4 Main Business and Markets Served 
7.8 Sanofi 
7.8.1 Sanofi Anti-Diabetic Drugs Production Sites and Area Served 
7.8.2 Anti-Diabetic Drugs Product Introduction, Application and Specification 
7.8.3 Sanofi Anti-Diabetic Drugs Production, Revenue, Price and Gross Margin (2014-2019) 
7.8.4 Main Business and Markets Served 
7.9 Teva Pharmaceutical Industries 
7.9.1 Teva Pharmaceutical Industries Anti-Diabetic Drugs Production Sites and Area Served 
7.9.2 Anti-Diabetic Drugs Product Introduction, Application and Specification 
7.9.3 Teva Pharmaceutical Industries Anti-Diabetic Drugs Production, Revenue, Price and Gross Margin (2014-2019) 
7.9.4 Main Business and Markets Served

Continued….

Contact Info:
Name: NORAH TRENT
Email: Send Email
Organization: WISE GUY RESEARCH CONSULTANTS PVT LTD
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar Pune - 411028 Maharashtra, India
Phone: 841 198 5042
Website: https://www.wiseguyreports.com/reports/3825670-global-anti-diabetic-drugs-market-research-report-2019

Source URL: https://marketersmedia.com/anti-diabetic-drugs-market-2019-global-analysis-opportunities-and-forecast-to-2025/494776

Source: MarketersMedia

Release ID: 494776

Latest News

Global stocks recover some ground at end of turbulent week

Aug 18, 2019

LONDON — Global stock markets looked set to end a turbulent week on a positive note although worries about the U.S. economy and the trade conflict between the U.S. and China still have the potential to derail Friday's recovery. Investors in stocks were spooked earlier this week by developments in the U.S. bond market, which was pricing in a likely recession next year. Add in worries over the trade conflict between Washington and Beijing, Brexit, weak economic performance in Germany and political unrest in Hong Kong and stock markets have endured one of their worst weeks this year. On Friday,...

Ex-Treasury chief: Boris Johnson wrecking Brexit deal chance

Aug 18, 2019

LONDON — The man who was Britain's top finance official until three weeks ago accused Prime Minister Boris Johnson's Conservative government on Wednesday of steering the country toward a damaging no-deal Brexit that isn't backed by Parliament or the voters. Philip Hammond, a Conservative legislator who stepped down as Treasury chief just before Johnson became prime minister last month, said "leaving the EU without a deal would be just as much a betrayal of the referendum result as not leaving at all." Hammond told the BBC that Johnson had moved from a tough negotiating stance to a "wrecking" one by...

Bolton says US ready to negotiate post-Brexit trade pact

Aug 18, 2019

LONDON — The United States is ready to negotiate a post-Brexit trade deal with the U.K. "in pieces" to help speed the process as Britain prepares to leave the European Union on Oct. 31, National Security Adviser John Bolton said Monday. Bolton told reporters after meeting with British Prime Minister Boris Johnson in London that a piecemeal approach to trade negotiations was "not unprecedented" and talks between the U.S. and the U.K. could start with areas where the two sides are likely to agree. "I think here we see the importance and urgency of doing as much as we can...

UK economy shrinks for first time since 2012 as Brexit bites

Aug 18, 2019

LONDON — The British economy shrank in the second quarter for the first time in six and a half years as Brexit uncertainties weighed on business investment and firms reduced their stockpiling of goods after Britain was granted an extension to its departure from the European Union, official figures showed Friday. The decline, the first since the fourth quarter of 2012, was a surprise, with most economists expecting the economy to flat-line. The Office for National Statistics said the contraction came "at a time of increased volatility around the U.K.'s original planned exit date from the European Union in late...

Flights canceled as British Airways hit by computer problem

Aug 18, 2019

LONDON — British Airways canceled almost 100 flights to and from London airports on Wednesday after its check-in systems were hit by computer problems. The airline said a "systems issue" was causing delays and cancellations for short-haul flights from Heathrow, Gatwick and London City airports. British Airways said it was relying on back-up and manual systems, and canceled 81 flights due to operate to, or from Heathrow, and 10 Gatwick flights, stranding some 15,000 passengers. More than 200 other flights were delayed. "A number of flights continue to operate but we are advising customers to check ba.com for the latest...

Financial Markets

Market Sanctum is one of the world’s leading news sources for the currency trading community. Our analysts report on the latest changes in the current market, providing in-depth analysis.

Contact us: sales[at]marketsanctum.com